RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
69 hedge funds and large institutions have $84.5M invested in Regulus Therapeutics in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
4.96% less ownership
Funds ownership: 86.65% → 81.69% (-5%)
5% less capital invested
Capital invested by funds: $89.1M → $84.5M (-$4.54M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
69
Holding in Top 10
–
Calls
$38K
Puts
$11K
Top Buyers
| 1 | +$1.42M | |
| 2 | +$924K | |
| 3 | +$246K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$246K |
| 5 |
JPMorgan Chase & Co
New York
|
+$176K |
Top Sellers
| 1 | -$3.37M | |
| 2 | -$1.49M | |
| 3 | -$840K | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$679K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$510K |